InsiderClue
Insiders · Profile

Hasnain Faheem

Director at Kura Oncology · President & CEO at Gossamer Bio · Director at Forte Biosciences · and 2 more. Filing since 2 Oct 2006. CIK 0001352620

KURA Kura Oncology, Inc. Director · 2 trades GOSS Gossamer Bio, Inc. President & CEO · 9 trades FBRX Forte Biosciences, Inc. Director · 2 trades IMUX IMMUNIC, INC. Director · 3 trades BIIB Biogen EVP, Oncology/Rheumatology SBU · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
KURA Kura Oncology, Inc.
9 Dec 2025
Director
Sold at will
10,000
$109.76K
29.4%
KURA Kura Oncology, Inc.
21 Mar 2025
Director
Sold at will
22,682
$181.46K
48.6%
GOSS Gossamer Bio, Inc.
21 Jun 2024
President & CEO
Bought
372,000
$250.28K
7.4%
GOSS Gossamer Bio, Inc.
27 Mar 2024
President & CEO
Sold at will
23,172
$26.77K
16.2%
GOSS Gossamer Bio, Inc.
22 Mar 2023
President & CEO
Bought
440,500
$503.58K
10.9%
GOSS Gossamer Bio, Inc.
21 Mar 2023
President & CEO
Bought
269,389
$322.32K
7.1%
GOSS Gossamer Bio, Inc.
20 Mar 2023
President & CEO
Bought
168,683
$174.49K
4.7%
GOSS Gossamer Bio, Inc.
15 Jul 2022
President & CEO
Bought
138,696
$1,000.00K
4.0%
GOSS Gossamer Bio, Inc.
23 Mar 2022
President & CEO
Sold, plan not stated
19,035
$169.70K
11.7%
GOSS Gossamer Bio, Inc.
14 Oct 2020
Director
Bought
96,520
$1,000.00K
2.9%
GOSS Gossamer Bio, Inc.
27 Sep 2019
Director
Bought
10,000
$167.98K
0.3%
FBRX Forte Biosciences, Inc.
30 May 2019
Director
Bought
43,000
$200.31K
21.2%
IMUX IMMUNIC, INC.
13 Sep 2018
Director
Sold, plan not stated
177,443
$77.68K
97.5%
IMUX IMMUNIC, INC.
14 Sep 2017
Director
Bought
59,200
$247.87K
48.2%
FBRX Forte Biosciences, Inc.
19 Apr 2017
Director
Bought
100,000
$1.00M
97.2%
IMUX IMMUNIC, INC.
12 Aug 2016
Director
Bought
118,243
$700.00K
×26
BIIB Biogen
9 Jul 2008
EVP, Oncology/Rheumatology SBU
Sold, plan not stated
36,837
$2.29M
59.1%
BIIB Biogen
8 Apr 2008
EVP, Oncology/Rheumatology SBU
Sold, plan not stated
6,425
$414.21K
16.7%
BIIB Biogen
23 May 2007
SVP, Oncology SBU
Sold, plan not stated
7,446
$364.85K
22.3%
BIIB Biogen
2 Oct 2006
SVP, Oncology SBU
Sold, plan not stated
11,244
$501.77K
51.0%
20 decisions on file.